Oligon Therapeutics
PrivateLast Round
VC Round
Sep 23, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Oligon Therapeutics operates in Healthcare & Life Sciences and is based in Montreal. Its latest recorded funding round was a VC Round in September 2025.
Oligon Therapeutics is a biotechnology company that develops multimodal RNA therapeutics using its proprietary SeekR platform to target complex diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oligon Therapeutics Comparables
Compare Oligon Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Argonaute RNA | 84% | |
| City Therapeutics | 81% | |
| PRAMOMOLECULAR | 80% |
For institutional investors. Book with your work email.
Oligon Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Oligon Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investissement Québec | VC Round |
| CTI Life Sciences Fund | VC Round |
| Fonds de solidarité FTQ | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 33% MoM.
- May 15, 2026
Monthly visitors increased 68% MoM.
For institutional investors. Book with your work email.
Oligon Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Oligon Therapeutics's valuation, stock price, and market status.
Is Oligon Therapeutics a public or private company?
Oligon Therapeutics is a private company.
What is the current stock price of Oligon Therapeutics?
Oligon Therapeutics is a private company with no public stock price. Caplight tracks Oligon Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Oligon Therapeutics worth (valuation)?
Valuation information for Oligon Therapeutics is not publicly available.
Can I buy Oligon Therapeutics stock?
Oligon Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Oligon Therapeutics's last funding round?
Oligon Therapeutics's most recent funding round was VC Round on September 23, 2025.
Who are the main investors in Oligon Therapeutics?
Key investors in Oligon Therapeutics include CTI Life Sciences Fund.
Will Oligon Therapeutics IPO soon?
No public IPO plans have been announced for Oligon Therapeutics.
How can I track Oligon Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Oligon Therapeutics's secondary market activity and sign up for updates.